SEARCH

SEARCH BY CITATION

References

  • 1
    Cover TL, Blaser MJ. Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease, and gastric cancer. Am Soc Microbiol News 1995; 61: 216.
  • 2
    Russo F, Notarnicola M, Di Matteo G, et al. Detection of Helicobacter pylori cagA gene by polymerase chain reaction in faecal samples. Eur J Gastroenterol Hepatol 1999; 11: 2516.
  • 3
    Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 21115.
  • 4
    Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 57915.
  • 5
    Crabtree JE, Covacci A, Farmery SM, et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 1995; 48: 415.
  • 6
    Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulcer secretion protein. J Biol Chem 1995; 270: 17 771–7.
  • 7
    Warburton VJ, Everett S, Mapstone NP, Axon ATR, Hawkey P, Dixon MF. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol 1998; 51: 5561.
  • 8
    Peek RM Jr, Thompson SA, Donahue JP, et al. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Phys 1998; 110: 53144.
  • 9
    Van Doorn LJ, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998; 115: 5866.
  • 10
    Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999; 37: 22749.
  • 11
    Nishiya D, Shimoyama T, Fukuda S, Yoshimura T, Tanaka M, Munakata A. Evaluation of the clinical relevance of the iceA1 gene in patients with Helicobacter pylori infection in Japan. Scand J Gastroenterol 2000; 35: 369.
  • 12
    Janssen MJ, Van Oijen AH, Verbeek AL, Jansen JB, De Boer WA. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole. Aliment Pharmacol Ther 2001; 15: 61324.
  • 13
    Spiller RC. Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia? Eur J Gastroenterol Hepatol 1999; 11(Suppl. 2): S258.
  • 14
    Van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, De Boer WA. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut 2000; 46: 3216.
  • 15
    Oderda G, Rapa A, Chirboli E, Caradonna M, Bona G. The only good Helicobacter pylori is a dead Helicobacter pylori. The Lancet 1997; 350: 712.
  • 16
    Crabtree JE, Farmery SM, Lindley IJD, Figura N, Peichl P, Tompkins DS. CagA cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994; 47: 94550.
  • 17
    Lopez-Brea M, Martinez MJ, Domingo D, Sanchez I, Alarcon T. Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population. FEMS Immunol Med Microbiol 1999; 24: 1838.
  • 18
    Miehlke S, Kibler K, Kim JG, et al. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol 1996; 91: 13225.
  • 19
    Osella AR, Leoci C, Misciagna G, Di Leo A. Decreasing Helicobacter pylori prevalence in an area of southern Italy. Ital J Gastroenterol 1996; 28(Suppl. 2): A214(Abstract).
  • 20
    Tytgat GNJ. The Sydney system: endoscopic division–endoscopic appearances in gastritis/duodenitis. J Gastroenterol Hepatol 1991; 6: 22334.
  • 21
    Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996; 20: 116181.
  • 22
    Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: inter-observer consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 124959.
  • 23
    Lin TT, Yeh CT, Yang E, Chen PC. Detection of Helicobacter pylori by polymerase chain reaction assay using gastric biopsy specimens taken for CLO-test. J Gastroenterol 1996; 31: 32932.
  • 24
    Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 1992; 30: 192200.
  • 25
    Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high molecular mass major antigen of Helicobacter pylori. Infect Immun 1993; 61: 1799809.
  • 26
    Broutet N, Marais A, Lamouliatte H, et al. cagA status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J Clin Microbiol 2001; 39: 131922.
  • 27
    Censini S, Lange C, Xiang Z, et al. cagA, a pathogenicity island of Helicobacter pylori, encodes type-I specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14 648–53.
  • 28
    Akopyantz NS, Clifton SW, Kersulyte D, et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28: 3753.
  • 29
    Zanten SJ, Bradette M, Farley A, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999; 13: 28995.
  • 30
    Graham DY, Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter 2000; 5 (Suppl. 1): S39.
  • 31
    Malfertheiner P, Megraud F, O'Morain C, et al. The European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection – the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 16780.
  • 32
    Nogueira C, Figueiredo C, Carneiro F, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001; 158: 64754.
  • 33
    Yamasaki R, Yokota K, Akagi T, et al. Gastric mucosal immunity induced by Helicobacter pylori infection. Nihon Rinsho 2001; 59: 3428.